Reply to "Association of atopic dermatitis with Graves' disease and Hashimoto's thyroiditis: A case-control study in the All of Us research program"
- PMID: 37315802
- DOI: 10.1016/j.jaad.2023.05.079
Reply to "Association of atopic dermatitis with Graves' disease and Hashimoto's thyroiditis: A case-control study in the All of Us research program"
Keywords: Graves disease; Hashimoto thyroiditis; atopic dermatitis; eczema; general dermatology; thyroid.
Conflict of interest statement
Conflict of interest Dr Wu is or has been an investigator, consultant, or speaker for AbbVie, Almirall, Amgen, Arcutis, Aristea Therapeutics, Bausch Health, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, DermTech, Dr. Reddy's Laboratories, Eli Lilly, EPI Health, Galderma, Janssen, LEO Pharma, Mindera, Novartis, Pfizer, Regeneron, Samsung Bioepis, Sanofi Genzyme, Solius, Sun Pharmaceutical, UCB, and Zerigo Health. Dr Han is or has been an investigator, consultant/advisor, or speaker for AbbVie, Athenex, Boehringer Ingelheim, Bond Avillion, Bristol-Myers Squibb, Celgene Corporation, Dermavant, Eli Lilly, Janssen, LEO Pharma, MC2, Novartis, Ortho Dermatologics, PellePharm, Pfizer, Regeneron, Sanofi/Genzyme, SUN Pharmaceutical, and UCB. Authors Smith, Engel, and Javadi have no conflicts of interest to declare.
Comment on
-
Association of atopic dermatitis with Graves' disease and Hashimoto's thyroiditis: A case-control study in the All of Us research program.J Am Acad Dermatol. 2023 Oct;89(4):e175-e176. doi: 10.1016/j.jaad.2023.04.073. Epub 2023 Jun 12. J Am Acad Dermatol. 2023. PMID: 37315799 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
